Reshma Rangwala Karyopharm Therapeutics Inc. (KPTI) insider trading activity

Reshma Rangwala is EVP & Chief Medical Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 342,931 shares of KPTI, which is worth approximately $240,051. The most recent transaction as insider was on Apr 22, 2024, when has been sold 6,789 shares (Common Stock) at a price of $1.17 per share, resulting in proceeds of $7,943. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 343K

0% 3M change

116.73% 12M change

Total Value Held $240,051

Reshma Rangwala Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 22 2024	SELL Open market or private sale	$7,943 $1.17 p/Share	6,789 Reduced 1.94%	342,931 Common Stock
Mar 01 2024	SELL Open market or private sale	$7,162 $1.2 p/Share	5,969 Reduced 1.68%	349,720 Common
Feb 29 2024	SELL Open market or private sale	$18,330 $1.17 p/Share	15,667 Reduced 4.22%	355,689 Common
Feb 28 2024	BUY Grant, award, or other acquisition	-	198,959 Added 34.89%	371,356 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	14,167 Added 7.59%	172,397 Common Stock
Apr 20 2023	SELL Open market or private sale	$27,350 $4.04 p/Share	6,770 Reduced 4.1%	158,230 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	100,000 Added 37.74%	165,000 Common Stock
Apr 29 2022	BUY Grant, award, or other acquisition	-	65,000 Added 50.0%	65,000 Common Stock

Also insider at

ARAV

Aravive, Inc. Healthcare

Chief Medical Officer

Reshma Rangwala

EVP & Chief Medical Officer

Houston, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Value

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI

Account